Successful Osimertinib Rechallenge in a Patient with T790M-Mutant Non–Small Cell Lung Cancer after Osimertinib-Induced Interstitial Lung Disease

Eisaku Miyauchi; Masakazu Ichinose; Akira Inoue

首页> 外文期刊>Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer >Successful Osimertinib Rechallenge in a Patient with T790M-Mutant Non–Small Cell Lung Cancer after Osimertinib-Induced Interstitial Lung Disease

【24h】

Successful Osimertinib Rechallenge in a Patient with T790M-Mutant Non–Small Cell Lung Cancer after Osimertinib-Induced Interstitial Lung Disease

机译：成功的口味interinib在口鼻炎诱导的间质性肺病中患有T790M-突变体非小细胞肺癌的患者中的患者重新检查

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 |2017年第5期|共3页
作者
Eisaku Miyauchi; Masakazu Ichinose; Akira Inoue;
展开▼
作者单位

Department of Respiratory Medicine Tohoku University Graduate School of Medicine;

Department of Respiratory Medicine Tohoku University Graduate School of Medicine;

Department of Palliative Medicine Tohoku University School of Medicine;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Successful Osimertinib Rechallenge in a Patient with T790M-Mutant Non–Small Cell Lung Cancer after Osimertinib-Induced Interstitial Lung Disease [J] . Eisaku Miyauchi, Masakazu Ichinose, Akira Inoue Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第5期

机译：成功的口味interinib在口鼻炎诱导的间质性肺病中患有T790M-突变体非小细胞肺癌的患者中的患者重新检查
2. Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab [J] . Nobuaki Mamesaya, Hirotsugu Kenmotsu, Toshiaki Takahashi Investigational new drugs. . 2017,第6期

机译：在用Nivolumab治疗后，在Osimertinib诱导的间质肺病后，成功的Osimertinib在患有先进的非小细胞肺癌的患者中重新检查
3. Outcome in advanced non-small cell lung cancer patients with successful rechallenge after recovery from epidermal growth factor receptor tyrosine kinase inhibitor-induced interstitial lung disease [J] . Kashiwabara Kosuke, Semba Hiroshi, Fujii Shinji, Cancer chemotherapy and pharmacology. . 2017,第4期

机译：从表皮生长因子受体酪氨酸激酶抑制剂诱导的间质性肺疾病诱导的间质性肺病后，在先进的非小细胞肺癌患者中患者的结果成功重新检查
4. Interstitial Lung Diseases/Diffuse Parenchymal Lung Diseases in Dogs and Cats [C] . American College of Veterinary Internal Medicine Forum Conference . 2018

机译：狗和猫的间质性肺病/弥漫性实质肺病
5. The cost effectiveness of screening for early stage lung cancer and the testing and treatment of molecular subgroups among non-small cell lung cancer patients in the province of ontario, canada [D] . Thao, Mallory. 2014

机译：加拿大安大略省非小细胞肺癌患者早期肺癌筛查的成本效益及分子亚群的检测和治疗
6. Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab [O] . Nobuaki Mamesaya, Hirotsugu Kenmotsu, Toshiaki Takahashi -1

机译：尼古鲁单抗治疗后由奥西替尼诱导的间质性肺疾病导致晚期非小细胞肺癌患者成功进行奥西替尼再挑战
7. Successful Osimertinib Rechallenge After Osimertinib-induced Interstitial Lung Disease in a Patient with Postoperative Recurrence of Lung Cancer [O] . Tsubasa Matsuo, Kazuhiro Imai, Shinogu Takashima, 2019

机译：成功的口莫特尼在肺癌术后复发患者患者中患者中的口服肾病诱导的间质性肺病

Successful Osimertinib Rechallenge in a Patient with T790M-Mutant Non–Small Cell Lung Cancer after Osimertinib-Induced Interstitial Lung Disease

著录项

相似文献

相关主题

期刊订阅